Infliximab or steroids may be more effective than anakinra as adjunctive therapy for children with MIS-C who do not respond to IVIG.
News|Articles|May 1, 2025
Full recap from the 2025 Pediatric Academic Societies meeting
Author(s)Joshua Fitch, Senior Editor
Fact checked by: Morgan Ebert, Executive Editor
In this article, we recap our top stories, expert interviews, and Q+A discussions from the 2025 Pediatric Academic Societies meeting.
Advertisement
Advertisement
The
Related to this article
Sleep specialist Rashi Kochhar, MD, explains how consistent bedtimes and wake times can support adequate sleep and daytime functioning during the school year.
A national claims analysis found 16.8% of pediatric GLP-1 users developed a nutritional deficiency within a year, most often vitamin D, while few received nutritional counseling.
Consistent sleep schedules can ease the back-to-school transition for children and teens
Adding questions about routines and predictability may provide pediatricians with a broader picture of childhood adversity and mental health risk.
Researchers found that childhood unpredictability provided additional information about mental health risk beyond conventional ACEs screening.
The FDA granted satralizumab priority review for MOGAD after phase 3 findings showed a 68% reduction in relapse risk versus placebo.
Suicide-related pediatric ED visits rose 74% from 2016 to 2022; about half occurred at EDs with lower pediatric volume, a national analysis found.
Advertisement
Advertisement